Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·-0.87%·₹590.4
Key EventAppointment of Pradeep Kumar Yadav as Senior General Manager-Quality Assurance
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·-0.87%·₹590.4
Key EventResignation of Head of QA effective September 24, 2026
ImpactThis leadership change may temporarily affect quality oversight but the company assures no disruption to operations.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·-1.23%·₹595.6
Key EventTrading window closes for quarterly results
ImpactShareholders must avoid trading during the closed window to prevent insider trading violations.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·+2.3%·₹633
Key EventLincoln Pharmaceuticals scheduled its 32nd AGM for September 30, 2026, via video conference.
ImpactThe company is prioritizing R&D and global expansion to drive future growth.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·+2.3%·₹633
Key Event32nd AGM scheduled for September 30, 2026
ImpactShareholders will vote on financial approvals and director reappointments at the upcoming AGM.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·+2.3%·₹633
Key EventCompany informs shareholders without registered emails to access Annual Report via website link.
ImpactShareholders with physical holdings must update KYC details to avoid payment disruptions and ensure continued access to communications.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·-1.29%·₹607.6
Key EventFinal dividend of ₹1.80 per share proposed for FY 2025-26
ImpactShareholders must hold shares by September 11 to qualify for the dividend payout.Sign up to read impact
Lincoln Pharmaceuticals Ltd (LINCOLN)
·Next Day Close·-1.29%·₹607.6
Key EventAGM scheduled to approve final dividend
ImpactShareholders must attend the AGM to approve the dividend before it becomes payable.Sign up to read impact
Lincoln Pharmaceuticals Limited (LINCOLN)
·Next Day Close·-0.86%·₹612.85
Key EventBoard approved Q1 FY27 consolidated financial results and recommended 18% dividend
ImpactStrong quarterly growth and dividend recommendation signal healthy momentum and shareholder-friendly policySign up to read impact
Lincoln Pharmaceuticals Limited (LINCOLN)
·Next Day Close·+4.7%·₹629.75
Lincoln Pharmaceuticals announced that its trading window will close on July 1, 2026, and remain closed until 48 hours after the unaudited financial results for the quarter ended June 30, 2026 are declared. The board meeting to approve these results will be scheduled at a later date. The notice emphasizes compliance with SEBI regulations and prohibits insiders from trading during this period.
Sign up to read summary